The tech company that uses artificial intelligence to detect diseases has around 30 people in Portugal and wants to reach 60 this year.
Viz.ai has raised $100 million (€91.7 million) in a Series D round, reaching a $1.2 million valuation and achieving unicorn status. The tech company, which develops innovative Artificial Intelligence solutions for the health sector, wants to double its team to 500 employees in the engineering sector. In Portugal it has around 30 people and wants to reach 60 until the end of the year.
“Viz.ai is committed to helping patients get better, faster and more equitable access to life saving treatments,” stresses Chris Mansi, co-founder and CEO of Viz.ai, quoted in a statement.
“We will continue to invest heavily in cutting edge technology and services to integrate deeply into the clinical workflow, allowing us to automate disease detection, increase diagnostic rates and enhance workflows across the entire hub and spoke health system. More patients receive the right treatment, resulting in better patient outcomes and improved financial efficiency for the health system,” he concludes.
The Series D round was led by Tiger Global and Insight Partners, but Scale Ventures, Kleiner Perkins, Threshold, Google Ventures, Sozo Ventures, CRV and Susa also participated.
Expanding the platform – for additional disease detection and screening – and growing its customer base globally are among the goals of this operation.
The company aims to double its engineering team to 500 employees. This growth objective also involves Portugal, where it already has a team of 30 people.
“Last year we had significant growth in Portugal, growth that we want to continue to focus on in 2022. Being a key country for us, it is our intention to establish partnerships with a number of more healthcare entities across the territory and strengthen hiring. The Portuguese technological talent continues to surprise us and we believe it will play a fundamental role in our mission to save lives and improve patient care on a global level,” said David Golan, CTO of Viz.ai, in a statement.
The company is seeking talent for the roles of Android, iOS and Engineering Manager.
Located in the US, Israel, Portugal and the Netherlands, Viz.ai uses Artificial Intelligence to increase the speed of diagnosis and treatment of a variety of acute and emergent diseases.